Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-26489112 in Photosensitive Epilepsy
NCT00579384Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Oct 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of JNJ-26489112 in photosensitive epilepsy (PSE), sponsored by Johnson & Johnson. Started Oct 2007; status: completed.
02
Drugs
JNJ-26489112
03
Conditions
photosensitive epilepsy (PSE)
Beyond the preview
Go deeper on NCT00579384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00579384.